Publication | Closed Access

DSM-RX78, a new phosphodiesterase inhibitor, suppresses superoxide anion production in activated human neutrophils and attenuates hemorrhagic shock-induced lung injury in rats

Acute Lung InjuryInflammationNew Phosphodiesterase InhibitorAnti-inflammatoryInflammatory Lung DiseaseActivated Human NeutrophilsLung InflammationMedicineImmunologySuperoxide Anion ProductionPulmonary PharmacologyVascular BiologyReactive Oxygen SpeciePharmacologyOxidative StressTissue Injury